Literature DB >> 18605975

Human oncogenic viruses: hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis.

V E Gurtsevitch1.   

Abstract

Chronic infections caused by hepatitis B virus (HBV) and/or hepatitis C virus (HCV) are the main risk factors for the development of hepatocellular carcinoma (HCC) in humans. Both viruses cause a wide spectrum of clinical manifestations ranging from healthy carrier state to acute and chronic hepatitis, liver cirrhosis, and HCC. HBV and HCV belong to different viral families (Hepadnoviridae and Flaviviridae, respectively); they are characterized by different genetic structures. Clinical manifestations of these viral infections result from the interaction between these viruses and host hepatocytes (i.e. between viral and cell genomes). Proteins encoded by both viruses play an important role in processes responsible for immortalization and transformation of these cells. Chronic inflammation determined by host immune response to the viral infection, hepatocyte death and their compensatory proliferation, as well as modulation of expression of some regulatory proteins of the cell (growth factors, cytokines, etc.) are the processes that play the major role in liver cancer induced by HBV and HCV.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18605975     DOI: 10.1134/s0006297908050039

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  31 in total

Review 1.  Viral manipulation of DNA repair and cell cycle checkpoints.

Authors:  Mira S Chaurushiya; Matthew D Weitzman
Journal:  DNA Repair (Amst)       Date:  2009-05-26

2.  Liver stiffness measurement in the risk assessment of hepatocellular carcinoma for patients with chronic hepatitis.

Authors:  Yuan-Hung Kuo; Sheng-Nan Lu; Chao-Hung Hung; Kwong-Ming Kee; Chien-Hung Chen; Tsung-Hui Hu; Chuan-Mo Lee; Chi-Sin Changchien; Jing-Houng Wang
Journal:  Hepatol Int       Date:  2010-10-08       Impact factor: 6.047

3.  The hepatoprotective effect of coumarin and coumarin derivates on carbon tetrachloride-induced hepatic injury by antioxidative activities in rats.

Authors:  Mukadder Atmaca; Hakkı Murat Bilgin; Basra Deniz Obay; Hüda Diken; Mustafa Kelle; Ebru Kale
Journal:  J Physiol Biochem       Date:  2011-06-09       Impact factor: 4.158

Review 4.  Immunotherapeutic approaches to hepatocellular carcinoma treatment.

Authors:  Alexander G Miamen; Haidong Dong; Lewis R Roberts
Journal:  Liver Cancer       Date:  2012-11       Impact factor: 11.740

5.  Screening serum biomarkers for early primary hepatocellular carcinoma using a phage display technique.

Authors:  Zhejia Zhang; Linyong Xu; Zhiming Wang
Journal:  J Clin Lab Anal       Date:  2011-11       Impact factor: 2.352

6.  Overexpression of Survivin-1, TAG-72 and HERC5 in patients diagnosed with hepatocellular carcinoma in the Black Sea coast geographical area.

Authors:  Andra-Iulia Suceveanu; Ioan Sergiu Micu; Gabriela-Izabela Baltatescu; Lucian Cristian Petcu; Nicolae Dobrin; Costel Brinzan; Cornelia Nitipir; Laura Mazilu; Florin Botea; Vlad Herlea; Felix Voinea; Adrian Paul Suceveanu
Journal:  Exp Ther Med       Date:  2021-01-26       Impact factor: 2.447

7.  Evaluation of midkine as a diagnostic serum biomarker in hepatocellular carcinoma.

Authors:  Wen-Wei Zhu; Jia-Jian Guo; Lei Guo; Hu-Liang Jia; Ming Zhu; Ju-Bo Zhang; Christopher A Loffredo; Marshonna Forgues; Hua Huang; Xu-Jian Xing; Ning Ren; Qiong-Zhu Dong; Hai-Jun Zhou; Zheng-Gang Ren; Nai-Qing Zhao; Xin Wei Wang; Zhao-You Tang; Lun-Xiu Qin; Qing-Hai Ye
Journal:  Clin Cancer Res       Date:  2013-05-29       Impact factor: 12.531

8.  Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategies.

Authors:  Denis Selimovic; Abdelouahid El-Khattouti; Hanan Ghozlan; Youssef Haikel; Ola Abdelkader; Mohamed Hassan
Journal:  World J Hepatol       Date:  2012-12-27

Review 9.  IL-22: a promising candidate to inhibit viral-induced liver disease progression and hepatocellular carcinoma.

Authors:  Muhammad Saalim; Saleha Resham; Sobia Manzoor; Hassam Ahmad; Shahla Jaleel; Javed Ashraf; Muhammad Imran; Sidrah Naseem
Journal:  Tumour Biol       Date:  2015-11-05

10.  Most common genotypes and risk factors for HCV in Gaza strip: a cross sectional study.

Authors:  Basim M Ayesh; Sofia S Zourob; Salah Y Abu-Jadallah; Yonat Shemer-Avni
Journal:  Virol J       Date:  2009-07-16       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.